공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

바이러스 항원 시장 : COVID-19의 영향과 세계 시장 분석 - 예측(-2027년)

Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Component, Technique, and End User and Geography

리서치사 The Insight Partners
발행일 2020년 12월 상품 코드 983349
페이지 정보 영문 200 Pages
가격
US $ 4,500 ₩ 5,195,000 PDF (Single User License)
US $ 6,500 ₩ 7,504,000 PDF (Site License)
US $ 8,500 ₩ 9,813,000 PDF (Enterprise License)


바이러스 항원 시장 : COVID-19의 영향과 세계 시장 분석 - 예측(-2027년) Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Component, Technique, and End User and Geography
발행일 : 2020년 12월 페이지 정보 : 영문 200 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

바이러스 항원 시장은 2019년 1억 141만 달러에서 2027년까지 2억 3,680만 달러에 달하고, 2020-2027년간 연평균 복합 성장률(CAG) 11.0%의 성장이 예측됩니다.

세계의 바이러스 항원(Viral Antigens) 시장에 대해 조사분석했으며, 시장 구도, 시장 역학, 부문별 시장 분석, 지역별 시장 분석, 경쟁 구도, 주요 기업에 대한 정보를 제공합니다.

목차

제1장 서론

제2장 바이러스 항원 시장 : 요점

제3장 조사 방법

제4장 바이러스 항원 시장 : 시장 구도

  • 개요
  • PEST 분석
  • 전문가의 견해

제5장 바이러스 항원 시장 : 주요 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 영향 분석

제6장 바이러스 항원 시장 : 세계 분석

  • 세계의 바이러스 항원 시장 매출 예측과 분석
  • 세계의 바이러스 항원 시장 : 지역별 - 예측과 분석
  • 주요 기업의 시장 포지셔닝

제7장 바이러스 항원 시장 : 성분별

  • 개요
  • 바이러스 항원 시장 점유율 : 성분별
  • 인플루엔자 바이러스 항원
  • 코로나 바이러스 항원
  • 지카 바이러스 항원
  • 에볼라 바이러스 항원
  • 뎅기 바이러스 항원
  • 단순 헤르페스 바이러스(HSV) 항원
  • 로타 바이러스 항원
  • A-E형 간염 바이러스 항원
  • 홍역 바이러스 항원
  • 유행성 이하선염/이하선염 바이러스 항원
  • 기타

제8장 바이러스 항원 시장 분석 : 기술별

  • 개요
  • 바이러스 항원 시장 매출 점유율 : 기술별
  • ELISA
  • 면역분석법
  • 혈구응집
  • 방사면역측정법(RIA)
  • 면역과산화효소 염색
  • 면역형광
  • 기타

제9장 바이러스 항원 시장 분석 : 최종사용자별

  • 개요
  • 바이러스 항원 시장 점유율 : 최종사용자별
  • 병원
  • 클리닉
  • 실험실
  • 진단센터
  • 혈액은행
  • 연구기관

제10장 바이러스 항원 시장 : 지역별 분석

  • 북미 : 바이러스 항원 시장
  • 유럽 : 바이러스 항원 시장
  • 아시아태평양 : 바이러스 항원 시장
  • 중동 및 아프리카 : 바이러스 항원 시장
  • 중남미 : 바이러스 항원 시장

제11장 세계 바이러스 항원 시장에 대한 COVID-19 팬데믹의 영향

  • 북미 : COVID-19 팬데믹의 영향 평가
  • 유럽 : COVID-19 팬데믹의 영향 평가
  • 아시아태평양 : COVID-19 팬데믹의 영향 평가
  • 중동 및 아프리카 : COVID-19 팬데믹의 영향 평가
  • 중남미 : COVID-19 팬데믹의 영향 평가

제12장 세계의 바이러스 항원 시장 : 업계 상황

  • 개요
  • 시장 기업의 성장 전략
  • 유기적 발전
  • 무기적 발전

제13장 기업 개요

  • Microbix Biosystems
  • BIO-RAD LABORATORIES INC.
  • Creative Diagnostics
  • Aalto Bio Reagents Ltd.
  • Advanced Biotechnologies Inc.
  • Prospec-Tany Technogene Ltd.
  • ACROBiosystems.
  • MERIDIAN BIOSCIENCE, INC.
  • Rekom Biotech S.L
  • LGC Limited.

제14장 부록

LSH 21.02.04

List Of Tables

  • Table 1. Viral Antigens Market Share, by Component, 2019 and 2027 (%)
  • Table 2. North America Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Europe Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Europe Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Europe Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Europe: Viral Antigens Market, by Country, 2019 & 2027 (%)
  • Table 18. Germany Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Germany Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Germany Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 21. UK Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 22. UK Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 23. UK Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 24. France Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 25. France Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 26. France Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Spain: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Spain Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Spain Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Spain Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Italy Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Italy Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Italy Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Rest of Europe Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Rest of Europe Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Rest of Europe Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Asia Pacific Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Asia Pacific Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Asia Pacific Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 40. China Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 41. China Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 42. China Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Japan Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Japan Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Japan Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 46. India Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 47. India Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 48. India Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 49. South Korea Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 50. South Korea Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 51. South Korea Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Australia Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Australia Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Australia Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Rest of Asia Pacific Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 56. Rest of Asia Pacific Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 57. Rest of Asia Pacific Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 58. Middle East & Africa Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 59. Middle East & Africa Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 60. Middle East & Africa Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 61. Saudi Arabia Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 62. Saudi Arabia Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Saudi Arabia Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 64. UAE Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 65. UAE Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 66. UAE Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 67. South Africa Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 68. South Africa Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 69. South Africa Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Rest of Middle East and Africa Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Rest of Middle East and Africa Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Rest of Middle East and Africa Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 73. South and Central America Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 74. South and Central America Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 75. South and Central America Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Brazil Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 77. Brazil Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Brazil Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 79. Argentina Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 80. Argentina Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 81. Argentina Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 82. Rest of Central and South America Viral Antigens Market, by Component - Revenue and Forecast to 2027 (USD Million)
  • Table 83. Rest of Central and South America Viral Antigens Market, by Technique - Revenue and Forecast to 2027 (USD Million)
  • Table 84. Rest of Central and South America Viral Antigens Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 85. Organic Developments Done By Companies
  • Table 86. Inorganic Developments Done By Companies
  • Table 87. Glossary of Terms, Viral antigens Market

List Of Figures

  • Figure 1. Viral Antigens Market Segmentation
  • Figure 2. Viral Antigens Market, By Region
  • Figure 3. Global Viral Antigens Market Overview
  • Figure 4. The Coronavirus Antigens Segment Held Largest Share of Component Segment In Viral Antigens Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Viral Antigens Market, By Geography (USD Million)
  • Figure 7. Global Viral Antigens Market- Leading Country Markets (USD Million)
  • Figure 8. Global Viral Antigens Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Expert Opinion
  • Figure 15. Global Viral Antigens Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Viral Antigens Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Viral Antigens Market
  • Figure 18. Viral Antigens Market Share, by Component, 2019 and 2027 (%)
  • Figure 19. Influenza Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 20. Coronavirus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 21. Zika Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 22. Ebola Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 23. Dengue Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 24. Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 25. Rotavirus Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 26. Hepatitis A-E Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 27. Measles Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 28. Mumps/Parotitis Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Others: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Viral Antigens Market Revenue Share, by Technique (2019 and 2027)
  • Figure 31. ELISA: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Immunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Hemagglutination: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. Radioimmunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 35. Immunoperoxidase Staining: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 36. Immunofluorescence: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 37. Others: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 38. Viral Antigens Market Share, by End User, 2019 and 2027 (%)
  • Figure 39. Hospitals: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 40. Clinics: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 41. Laboratories: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 42. Diagnostic Centres: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 43. Blood Banks: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 44. Research Institutes: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 45. North America: Viral Antigens Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. North America Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
  • Figure 47. North America: Viral Antigens Market, by Country, 2019 & 2027 (%)
  • Figure 48. US: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Canada: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Mexico: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Europe: Viral Antigens Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 52. Europe Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Europe: Viral Antigens Market, by Country, 2019 & 2027 (%)
  • Figure 54. Germany: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. UK: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. France: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Spain: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. Italy: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Rest of Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Asia Pacific: Viral Antigens Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 61. Asia Pacific Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
  • Figure 62. China: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Japan: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. India: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. South Korea: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Australia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. Rest of Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 68. Middle East & Africa: Viral Antigens Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 69. Middle East & Africa Viral Antigens Market Revenue and Forecast to 2027 (USD Million)
  • Figure 70. Middle East & Africa: Viral Antigens Market, by Country, 2019 & 2027 (%)
  • Figure 71. Saudi Arabia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 72. UAE: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 73. South Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 74. Rest of Middle East and Africa: Pulse Oximeters Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 75. South and Central America: Viral Antigens Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 76. South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
  • Figure 77. South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
  • Figure 78. Brazil: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 79. Argentina: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 80. Rest of Central and South America: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 81. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 82. Impact of COVID-19 Pandemic in Europe Country Markets
  • Figure 83. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
  • Figure 84. Impact of COVID-19 Pandemic in Middle East & Africa Market
  • Figure 85. Impact of COVID-19 Pandemic in South and Central America Market
  • Figure 86. Growth Strategies Done by the Companies in the Market, (%)

The viral antigens market was valued at US$ 101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020-2027. The growth of the market is attributed to the increased acceptance of viral antigens in vaccine development, and advancements in image analysis software and informatics platforms for viral antigen detection. Further, the emerging markets offer lucrative opportunities to the global viral antigens market players. However, the high cost of vaccine development hinders the market growth.

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A viralus antigen is a poison or toxic substance administered by by a virus these virulent entities, which that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. For instance, Aa viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

Based on component, the global viral antigens market is sub-segmented into Iinfluenza Vviral antigens, Ccoronavirus antigens, Zika Vvirus Aantigens, Ebola Aantigens, Dengue Aantigens, Herpes Simplex Vvirus (HSV) Aantigens, Rrotavirus antigens, Hepatitis A-E antigens, Mmeasles antigens, mumps/parotitis antigens, and others. The Coronavirus antigens segment held the largest share of the market in 2019, and it is expected to register a the higher highest CAGR during the forecast period. Based on technique, the global viral antigens market is segmented into ELISA, immunoassay, hemagglutination, Rradioimmunoassay (RIA), immunoperoxidase staining, immunofluorescence, and others. The clinics segment held the largest share of the market in 2019, and is expected to register the highest CAGR during the forecast period. Based on end user, the global viral antigens market is segmented into hospitals, clinics, laboratories, diagnostic centers, blood banks, and research institutes. The diagnostic centers segment held the largest share of the market in 2019, and the market for laboratories is expected to register grow at the highest CAGR during the forecast period.

The US Food and Drug Administration (FDA), Centers for Disease Control and Prevention's (CDC), and National Health Agency (ANVISA) are among a few secondary sources referred to for preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the viral antigens market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global viral antigens market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Viral Antigens Market - By Component
    • 1.3.2 Global Viral Antigens Market - By Technique
    • 1.3.3 Global Viral Antigens Market - By End User
    • 1.3.4 Global Viral Antigens Market - By Geography

2. Viral Antigens Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Viral Antigens Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America- PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa
    • 4.2.5 South & Central America
  • 4.3 Expert Opinion

5. Viral Antigens Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increased Acceptance of Viral Antigens in Vaccine Development
    • 5.1.2 Advancements in Image Analysis Software and Informatics Platforms for Viral Antigen Detection
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Vaccine Development
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Growing Trend of Plant-Made Vaccine Antigens and Biopharmaceuticals
  • 5.5 Impact Analysis

6. Viral Antigens Market - Global Analysis

  • 6.1 Global Viral Antigens Market Revenue Forecast And Analysis
  • 6.2 Global Viral Antigens Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Viral Antigens Market- By Component

  • 7.1 Overview
  • 7.2 Viral Antigens Market Share, by Component, 2019 and 2027 (%)
  • 7.3 Influenza Viral Antigens
    • 7.3.1 Overview
    • 7.3.2 Influenza Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.4 Coronavirus Antigens
    • 7.4.1 Overview
    • 7.4.2 Coronavirus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.5 Zika Virus Antigens
    • 7.5.1 Overview
    • 7.5.2 Zika Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.6 Ebola Virus Antigens
    • 7.6.1 Overview
    • 7.6.2 Ebola Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.7 Dengue Virus Antigens
    • 7.7.1 Overview
    • 7.7.2 Dengue Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.8 Herpes Simplex Virus (HSV) Viral Antigens
    • 7.8.1 Overview
    • 7.8.2 Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.9 Rotavirus Viral Antigens
    • 7.9.1 Overview
    • 7.9.2 Rotavirus Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.10 Hepatitis A-E Virus Antigens
    • 7.10.1 Overview
    • 7.10.2 Hepatitis A-E Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.11 Measles Virus Antigens
    • 7.11.1 Overview
    • 7.11.2 Measles Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.12 Mumps/Parotitis Virus Antigens
    • 7.12.1 Overview
    • 7.12.2 Mumps/Parotitis Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
  • 7.13 Others
    • 7.13.1 Overview
    • 7.13.2 Others: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)

8. Viral Antigens Market Analysis - By Technique

  • 8.1 Overview
  • 8.2 Viral Antigens Market Revenue Share, by Technique (2019 and 2027)
  • 8.3 ELISA
    • 8.3.1 Overview
    • 8.3.2 ELISA: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Immunoassay
    • 8.4.1 Overview
    • 8.4.2 Immunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Hemagglutination
    • 8.5.1 Overview
    • 8.5.2 Hemagglutination: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Radioimmunoassay (RIA)
    • 8.6.1 Overview
    • 8.6.2 Radioimmunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Immunoperoxidase Staining
    • 8.7.1 Overview
    • 8.7.2 Immunoperoxidase Staining: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.8 Immunofluorescence
    • 8.8.1 Overview
    • 8.8.2 Immunofluorescence: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)

9. Viral Antigens Market Analysis - By End User

  • 9.1 Overview
  • 9.2 Viral Antigens Market Share, by End User, 2019 and 2027, (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Clinics
    • 9.4.1 Overview
    • 9.4.2 Clinics: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Laboratories
    • 9.5.1 Overview
    • 9.5.2 Laboratories: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Diagnostic Centres
    • 9.6.1 Overview
    • 9.6.2 Diagnostic Centres: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Blood Banks
    • 9.7.1 Overview
    • 9.7.2 Blood Banks: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.8 Research Institutes
    • 9.8.1 Overview
    • 9.8.2 Research Institutes: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)

10. Viral Antigens Market - Geographic Analysis

  • 10.1 North America: Viral Antigens Market
    • 10.1.1 Overview
    • 10.1.2 North America: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.1.4 North America: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.1.5 North America: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.1.6 North America: Viral Antigens Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.1.7.3 US: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.1.7.4 US: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.1.8 Canada: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.1.8.3 Canada: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.1.8.4 Canada: viral antigens market, by End User, 2018-2027 (USD million)
    • 10.1.9 Mexico: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.1.9.3 Mexico: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.1.9.4 Mexico: Viral Antigens Market, by End User, 2018-2027 (USD million)
  • 10.2 Europe: Viral Antigens Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.2.4 Europe: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.2.5 Europe: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.2.6 Germany: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.6.1 Germany: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.6.2 Germany: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.2.6.3 Germany: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.2.6.4 Germany: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.2.7 UK: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 UK Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 UK: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.2.7.3 UK: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.2.7.4 UK: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.2.8 France: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 France: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 France: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.2.8.3 France: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.2.8.4 France: Viral Antigens Market, by End User, 2018-2027 (USD million)
      • 10.2.8.5 Spain: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.6 Spain: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.2.8.7 Spain: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.2.8.8 Spain: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.2.9 Italy: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 Italy: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 Italy: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.2.9.3 Italy: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.2.9.4 Italy: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.2.10 Rest of Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Rest of Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Rest of Europe: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.2.10.3 Rest of Europe: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.2.10.4 Rest of Europe: Viral Antigens Market, by End User, 2018-2027 (USD million)
  • 10.3 Asia Pacific: Viral Antigens Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.3.4 Asia Pacific: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.3.5 Asia Pacific: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.3.6 Asia Pacific: Viral Antigens Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.3.7.3 China: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.3.7.4 China: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.3.8 Japan: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.3.8.3 Japan: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.3.8.4 Japan: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.3.9 India: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.3.9.3 India: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.3.9.4 India: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.3.10 South Korea: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.3.10.3 South Korea: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.3.10.4 South Korea: Viral Antigens Market, by End User, 2018-2027 (USD million)
      • 10.3.10.5 Australia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.6 Australia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.7 Australia: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.3.10.8 Australia: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.3.10.9 Australia: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.3.11 Rest of Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Rest of Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Rest of Asia Pacific: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.3.11.3 Rest of Asia Pacific: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.3.11.4 Rest of Asia Pacific: Viral Antigens Market, by End User, 2018-2027 (USD million)
  • 10.4 Middle East & Africa: Viral Antigens Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
    • 10.4.3 Middle East & Africa: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.4.4 Middle East & Africa: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.4.5 Middle East & Africa: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.4.6 Middle East & Africa: Viral Antigens Market, by Country, 2019 & 2027 (%)
    • 10.4.7 Saudi Arabia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.4.7.3 Saudi Arabia: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.4.7.4 Saudi Arabia: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.4.8 UAE: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.4.8.3 UAE: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.4.8.4 UAE: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.4.9 South Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.4.9.3 South Africa: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.4.9.4 South Africa: Viral Antigens Market, by End User, 2018-2027 (USD million)
    • 10.4.10 Rest of Middle East and Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.1 Rest of Middle East and Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.10.2 Rest of Middle East and Africa: Viral Antigens Market, by Component, 2018-2027 (USD Million)
      • 10.4.10.3 Rest of Middle East and Africa: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
      • 10.4.10.4 Rest of Middle East and Africa: Viral Antigens Market, by End User, 2018-2027 (USD million)
  • 10.5 South and Central America: Viral Antigens Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
    • 10.5.3 South and Central America: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.5.4 South and Central America: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.5.5 South and Central America: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.5.6 South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Brazil: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.5.9 Brazil: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.5.10 Brazil: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.5.11 Argentina: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.11.1 Argentina: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.12 Argentina: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.5.13 Argentina: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.5.14 Argentina: Viral Antigens Market, by End User, 2018-2027 (USD Million)
    • 10.5.15 Rest of Central and South America: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.15.1 Rest of Central and South America: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
    • 10.5.16 Rest of Central and South America: Viral Antigens Market, by Component, 2018-2027 (USD Million)
    • 10.5.17 Rest of Central and South America: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
    • 10.5.18 Rest of Central and South America: Viral Antigens Market, by End User, 2018-2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Viral Antigens Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe (EU): Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Viral Antigens Market- Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Microbix Biosystems
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 BIO-RAD LABORATORIES INC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Creative Diagnostics
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Aalto Bio Reagents Ltd.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Advanced Biotechnologies Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Prospec-Tany Technogene Ltd.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 ACROBiosystems.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 MERIDIAN BIOSCIENCE, INC.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Rekom Biotech S.L
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 LGC Limited.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
Back to Top
전화 문의
F A Q